Published 5 days ago • loading... • Updated 5 days ago

MHRA Approves Guselkumab for Inflammatory Bowel Disease

Summary by Medscape

The MHRA has approved guselkumab to treat Crohn’s disease and ulcerative colitis in adults who have not responded to other therapies.

2 Articles

All

Left

Center

Right

The MHRA has approved guselkumab to treat Crohn’s disease and ulcerative colitis in adults who have not responded to other therapies.

5 days ago·United States

Regulator confirms safety and efficacy of new treatment option for patient

5 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated4 days agoBias Distribution

No sources with tracked biases.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

pharmatimes.com broke the news in 5 days ago on Monday, May 19, 2025.

Sources are mostly out of (0)